Trials / Completed
CompletedNCT05988346
Ghrelin and Diastolic Heart Function
Ghrelin Expression Could Regulate Diastolic Heart Function in Obese Patients With Diabetes
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- University of Campania Luigi Vanvitelli · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
In type 2 diabetes mellitus (T2DM) and obese patients the adipose tissue could over-express cytokines, sirtuin-1 (SIRT1), and microRNAs (miRs) implied in the regulation of left ventricle (LV) diastolic function (LV-DF). Ghrelin could modulate these pathways. Thus, in the current study authors will investigate ghrelin expression in T2DM obese patients after abdominal fat excision, and particularly in those with normalization of LV-DF at 1 year of follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | abdominal plastic intervention | According to international guidelines, authors will remove the superficial abdominal fat from the patients enrolled in the study. |
Timeline
- Start date
- 2016-01-01
- Primary completion
- 2022-01-01
- Completion
- 2022-03-01
- First posted
- 2023-08-14
- Last updated
- 2023-08-24
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05988346. Inclusion in this directory is not an endorsement.